These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34835109)

  • 1. The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion.
    Vanpouille C; Günaydın G; Jangard M; Clerici M; Margolis L; Broliden K; Introini A
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.
    Ray RM; Maritz MF; Avenant C; Tomasicchio M; Dlamini S; van der Spuy Z; Hapgood JP
    Sci Rep; 2019 Mar; 9(1):4334. PubMed ID: 30867477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.
    Huijbregts RP; Helton ES; Michel KG; Sabbaj S; Richter HE; Goepfert PA; Hel Z
    Endocrinology; 2013 Mar; 154(3):1282-95. PubMed ID: 23354099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
    Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP
    PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.
    Govender Y; Avenant C; Verhoog NJ; Ray RM; Grantham NJ; Africander D; Hapgood JP
    PLoS One; 2014; 9(5):e96497. PubMed ID: 24840644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
    Maritz MF; Ray RM; Bick AJ; Tomasicchio M; Woodland JG; Govender Y; Avenant C; Hapgood JP
    PLoS One; 2018; 13(4):e0196043. PubMed ID: 29698514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.
    Bick AJ; Avenant C; Tomasicchio M; van der Spuy Z; Hapgood JP
    Am J Reprod Immunol; 2022 Dec; 88(6):e13643. PubMed ID: 36302121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
    Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
    Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.
    Mnqonywa N; Abbai N; Ragupathy V; Ramjee G; Hewlett I; Moodley D
    BMC Res Notes; 2019 Nov; 12(1):745. PubMed ID: 31730016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.
    Woods MW; Zahoor MA; Dizzell S; Verschoor CP; Kaushic C
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29105931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone Acetate Regulates HIV-1 Uptake and Transcytosis but Not Replication in Primary Genital Epithelial Cells, Resulting in Enhanced T-Cell Infection.
    Ferreira VH; Dizzell S; Nazli A; Kafka JK; Mueller K; Nguyen PV; Tremblay MJ; Cochrane A; Kaushic C
    J Infect Dis; 2015 Jun; 211(11):1745-56. PubMed ID: 25538276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
    Hapgood JP; Ray RM; Govender Y; Avenant C; Tomasicchio M
    Am J Reprod Immunol; 2014 Jun; 71(6):505-12. PubMed ID: 24547700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants.
    Introini A; Boström S; Bradley F; Gibbs A; Glaessgen A; Tjernlund A; Broliden K
    PLoS Pathog; 2017 May; 13(5):e1006402. PubMed ID: 28542587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Cervical CD4
    Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
    Thurman A; Chandra N; Schwartz JL; Brache V; Chen BA; Asin S; Rollenhagen C; Herold BC; Fichorova RN; Hillier SL; Weiner DH; Mauck C; Doncel GF
    AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
    Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner.
    Louw-du Toit R; Hapgood JP; Africander D
    J Biol Chem; 2014 Nov; 289(45):31136-49. PubMed ID: 25202013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi.
    Zia Y; Tang JH; Chinula L; Tegha G; Stanczyk FZ; Kourtis AP
    Contraception; 2019 Nov; 100(5):402-405. PubMed ID: 31374188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
    AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.